Index Entries

Anna Onnis, Emanuele Andreano, Chiara Cassioli, Francesca Finetti, Chiara Della Bella, Oskar Staufer, Elisa Pantano, Valentina Abbiento, Giuseppe Marotta, Mario Milco D’Elios, Rino Rappuoli, and Cosima T. Baldari
November 15, 2022
Journal of Experimental Medicine
University of Siena (Italy)

"We have hypothesized that similar to viruses such as HIV-1 (Fackler et al., 2007), SARS-CoV-2 may target IS [immune synapse] assembly and function as a means to escape CTL [cytotoxic T lymphocyte]-mediated killing. We provide evidence that Spike suppresses IS assembly in CTLs, leading to impaired cytotoxicity and cytokine production."

document
COVID-19,immunodeficiency and immunopathological disorders,SARS-CoV-2 spike protein,vaccines